Scott Collins, PhD
Board of Directors President
I am passionate about eliminating the world’s problems through new and existing technologies alike. Most recently, I have applied this to human health. I can visualize the various pathways from technology creation to sustainable market, and guide companies more expeditiously towards success. I hate seeing companies flounder and technologies die on the vine. I like bringing clarity to ambiguity.
I am an experienced startup executive with cross-industry expertise spanning corporate formation through sale. I bring a multi-perspective approach to success, drawing from knowledge in entrepreneurship, biotechnology, tissue and organ engineering, biofabrication, communications, and software development. I am a creative out-of-the-box thinker who can combine existing technologies and novel innovations to sustainably solve problems and improve processes.
Hilary Graham, PhD, MA
Board of Directors Member
I’m storyteller and commercial strategist with a growth mindset specializing in the molecular diagnostics and life sciences markets. People are my passion… both customer satisfaction and team development.
I lead Marketing for the Molecular Diagnostics Division of Bio-Techne, which includes the Asuragen, Exosome Diagnostics, Armored Molecular Controls and Companion Diagnostics franchises. I’m responsible for portfolio strategy, product management, and content marketing. Previously to Bio-Techne, I led marketing and application science for the xMAP multiplexing franchise at Luminex and was leading the launch of the INTELLIFLEX system when I departed. Before joining Luminex I worked in a variety of commercial and technical communications roles at Syneos Health and UT MD Anderson Cancer Center.
Elisa Maldonado-Holmertz
Board of Directors Member
In addition to industry background, graduate work completed in Business Management and Health Economics. Elisa has several authorships and acknowledgments, including FDA Scientific Reports and submissions. Additionally, numerous presentations at CincyTech, Informa, InnoTech, Freescale Technology Forum, Plexus, DesignMed, and RAPS Convergence.
Elisa left her VP position at Emergo Group to create Obelix Biotech Solutions servicing the RA/QA needs of start-ups in order to reach their commercial goals.